title: The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients.
authors.affiliation: Dept of Respiratory Medicine, University Hospital Antwerp, Antwerp, Belgium.
authors.forename: Wilfried
authors.initials: W
authors.lastname: De Backer
authors.affiliation: Fluidda nv, Kontich, Belgium.
authors.forename: Wim
authors.initials: W
authors.lastname: Vos
authors.affiliation: Fluidda nv, Kontich, Belgium.
authors.forename: Cedric
authors.initials: C
authors.lastname: Van Holsbeke
authors.affiliation: Fluidda nv, Kontich, Belgium.
authors.forename: Samir
authors.initials: S
authors.lastname: Vinchurkar
authors.affiliation: Dept of Respiratory Medicine, University Hospital Antwerp, Antwerp, Belgium.
authors.forename: Rita
authors.initials: R
authors.lastname: Claes
authors.affiliation: Dept of Respiratory Medicine, University Hospital Antwerp, Antwerp, Belgium.
authors.forename: Annemie
authors.initials: A
authors.lastname: Hufkens
authors.affiliation: Dept of Radiology, University Hospital Antwerp, Antwerp, Belgium.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Parizel
authors.affiliation: Dept of Respiratory Medicine, ZNA Middelheim Hospital, Antwerp, Belgium.
authors.forename: Lieven
authors.initials: L
authors.lastname: Bedert
authors.affiliation: Fluidda nv, Kontich, Belgium Jan.DeBacker@Fluidda.com.
authors.forename: Jan
authors.initials: J
authors.lastname: De Backer
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D058666:Adrenergic beta-2 Receptor Agonists / Q000627:therapeutic use; D000631:Aminopyridines / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D018678:Cholinergic Agents / Q000627:therapeutic use*; D003521:Cyclopropanes / Q000627:therapeutic use; D017079:Exercise Tolerance; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000503:physiopathology; D010641:Phenotype; D058988:Phosphodiesterase 4 Inhibitors / Q000627:therapeutic use; D010991:Plethysmography; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D013147:Spirometry; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D000631:Aminopyridines; D001549:Benzamides; D018678:Cholinergic Agents; D003521:Cyclopropanes; D058988:Phosphodiesterase 4 Inhibitors; C424423:Roflumilast